
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
Hung–Chih Yang, Sifei Xing, Liang Shan, et al.
Journal of Clinical Investigation (2009)
Open Access | Times Cited: 259
Hung–Chih Yang, Sifei Xing, Liang Shan, et al.
Journal of Clinical Investigation (2009)
Open Access | Times Cited: 259
Showing 1-25 of 259 citing articles:
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Ya‐Chi Ho, Liang Shan, Nina N. Hosmane, et al.
Cell (2013) Vol. 155, Iss. 3, pp. 540-551
Open Access | Times Cited: 1334
Ya‐Chi Ho, Liang Shan, Nina N. Hosmane, et al.
Cell (2013) Vol. 155, Iss. 3, pp. 540-551
Open Access | Times Cited: 1334
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Gary Maartens, Connie Celum, Sharon R. Lewin
The Lancet (2014) Vol. 384, Iss. 9939, pp. 258-271
Closed Access | Times Cited: 766
Gary Maartens, Connie Celum, Sharon R. Lewin
The Lancet (2014) Vol. 384, Iss. 9939, pp. 258-271
Closed Access | Times Cited: 766
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan, Kai Deng, Neeta S. Shroff, et al.
Immunity (2012) Vol. 36, Iss. 3, pp. 491-501
Open Access | Times Cited: 692
Liang Shan, Kai Deng, Neeta S. Shroff, et al.
Immunity (2012) Vol. 36, Iss. 3, pp. 491-501
Open Access | Times Cited: 692
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Susanne Eriksson, Erin H. Graf, Viktor Dahl, et al.
PLoS Pathogens (2013) Vol. 9, Iss. 2, pp. e1003174-e1003174
Open Access | Times Cited: 551
Susanne Eriksson, Erin H. Graf, Viktor Dahl, et al.
PLoS Pathogens (2013) Vol. 9, Iss. 2, pp. e1003174-e1003174
Open Access | Times Cited: 551
Towards an HIV cure: a global scientific strategy
Steven G. Deeks, Brigitte Autran, Ben Berkhout, et al.
Nature reviews. Immunology (2012) Vol. 12, Iss. 8, pp. 607-614
Open Access | Times Cited: 539
Steven G. Deeks, Brigitte Autran, Ben Berkhout, et al.
Nature reviews. Immunology (2012) Vol. 12, Iss. 8, pp. 607-614
Open Access | Times Cited: 539
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
C. Korin Bullen, Gregory M. Laird, Christine M. Durand, et al.
Nature Medicine (2014) Vol. 20, Iss. 4, pp. 425-429
Open Access | Times Cited: 478
C. Korin Bullen, Gregory M. Laird, Christine M. Durand, et al.
Nature Medicine (2014) Vol. 20, Iss. 4, pp. 425-429
Open Access | Times Cited: 478
An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients
Celsa A. Spina, Jenny L. Anderson, Nancie M. Archin, et al.
PLoS Pathogens (2013) Vol. 9, Iss. 12, pp. e1003834-e1003834
Open Access | Times Cited: 398
Celsa A. Spina, Jenny L. Anderson, Nancie M. Archin, et al.
PLoS Pathogens (2013) Vol. 9, Iss. 12, pp. e1003834-e1003834
Open Access | Times Cited: 398
Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations
Gregory M. Laird, C. Korin Bullen, Daniel I. S. Rosenbloom, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 5, pp. 1901-1912
Open Access | Times Cited: 374
Gregory M. Laird, C. Korin Bullen, Daniel I. S. Rosenbloom, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 5, pp. 1901-1912
Open Access | Times Cited: 374
HIV-1 transcription and latency: an update
Carine Van Lint, Sophie Bouchat, Alessandro Marcello
Retrovirology (2013) Vol. 10, Iss. 1
Open Access | Times Cited: 313
Carine Van Lint, Sophie Bouchat, Alessandro Marcello
Retrovirology (2013) Vol. 10, Iss. 1
Open Access | Times Cited: 313
Targeting the Latent Reservoir for HIV-1
Srona Sengupta, Robert F. Siliciano
Immunity (2018) Vol. 48, Iss. 5, pp. 872-895
Open Access | Times Cited: 312
Srona Sengupta, Robert F. Siliciano
Immunity (2018) Vol. 48, Iss. 5, pp. 872-895
Open Access | Times Cited: 312
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends
Peng Zhan, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 7, pp. 2849-2878
Closed Access | Times Cited: 288
Peng Zhan, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 7, pp. 2849-2878
Closed Access | Times Cited: 288
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
Zichong Li, Jia Guo, Yuntao Wu, et al.
Nucleic Acids Research (2012) Vol. 41, Iss. 1, pp. 277-287
Open Access | Times Cited: 274
Zichong Li, Jia Guo, Yuntao Wu, et al.
Nucleic Acids Research (2012) Vol. 41, Iss. 1, pp. 277-287
Open Access | Times Cited: 274
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Nancie M. Archin, Julia Marsh Sung, Carolina Garrido, et al.
Nature Reviews Microbiology (2014) Vol. 12, Iss. 11, pp. 750-764
Open Access | Times Cited: 268
Nancie M. Archin, Julia Marsh Sung, Carolina Garrido, et al.
Nature Reviews Microbiology (2014) Vol. 12, Iss. 11, pp. 750-764
Open Access | Times Cited: 268
Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay
Gregory M. Laird, Evelyn E. Eisele, S. Alireza Rabi, et al.
PLoS Pathogens (2013) Vol. 9, Iss. 5, pp. e1003398-e1003398
Open Access | Times Cited: 240
Gregory M. Laird, Evelyn E. Eisele, S. Alireza Rabi, et al.
PLoS Pathogens (2013) Vol. 9, Iss. 5, pp. e1003398-e1003398
Open Access | Times Cited: 240
Reactivation of Latent HIV-1 by Inhibition of BRD4
Jian Zhu, Gaurav D. Gaiha, Sinu P. John, et al.
Cell Reports (2012) Vol. 2, Iss. 4, pp. 807-816
Open Access | Times Cited: 231
Jian Zhu, Gaurav D. Gaiha, Sinu P. John, et al.
Cell Reports (2012) Vol. 2, Iss. 4, pp. 807-816
Open Access | Times Cited: 231
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
Julian Elliott, James McMahon, Christina C. Chang, et al.
The Lancet HIV (2015) Vol. 2, Iss. 12, pp. e520-e529
Open Access | Times Cited: 231
Julian Elliott, James McMahon, Christina C. Chang, et al.
The Lancet HIV (2015) Vol. 2, Iss. 12, pp. e520-e529
Open Access | Times Cited: 231
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
Daniela Boehm, Vincenzo Calvanese, Roy D. Dar, et al.
Cell Cycle (2013) Vol. 12, Iss. 3, pp. 452-462
Open Access | Times Cited: 222
Daniela Boehm, Vincenzo Calvanese, Roy D. Dar, et al.
Cell Cycle (2013) Vol. 12, Iss. 3, pp. 452-462
Open Access | Times Cited: 222
Screening for noise in gene expression identifies drug synergies
Roy D. Dar, Nina N. Hosmane, Michelle R. Arkin, et al.
Science (2014) Vol. 344, Iss. 6190, pp. 1392-1396
Open Access | Times Cited: 217
Roy D. Dar, Nina N. Hosmane, Michelle R. Arkin, et al.
Science (2014) Vol. 344, Iss. 6190, pp. 1392-1396
Open Access | Times Cited: 217
Understanding HIV Latency: The Road to an HIV Cure
Matthew S. Dahabieh, Emilie Battivelli, Eric Verdin
Annual Review of Medicine (2015) Vol. 66, Iss. 1, pp. 407-421
Open Access | Times Cited: 203
Matthew S. Dahabieh, Emilie Battivelli, Eric Verdin
Annual Review of Medicine (2015) Vol. 66, Iss. 1, pp. 407-421
Open Access | Times Cited: 203
HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells
Leonard Chávez, Vincenzo Calvanese, Eric Verdin
PLoS Pathogens (2015) Vol. 11, Iss. 6, pp. e1004955-e1004955
Open Access | Times Cited: 202
Leonard Chávez, Vincenzo Calvanese, Eric Verdin
PLoS Pathogens (2015) Vol. 11, Iss. 6, pp. e1004955-e1004955
Open Access | Times Cited: 202
Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation
Jun Li, Cancan Chen, Xiancai Ma, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 188
Jun Li, Cancan Chen, Xiancai Ma, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 188
The mTOR Complex Controls HIV Latency
Emilie Besnard, Shweta Hakre, Martin Kampmann, et al.
Cell Host & Microbe (2016) Vol. 20, Iss. 6, pp. 785-797
Open Access | Times Cited: 182
Emilie Besnard, Shweta Hakre, Martin Kampmann, et al.
Cell Host & Microbe (2016) Vol. 20, Iss. 6, pp. 785-797
Open Access | Times Cited: 182
Establishment of HIV Latency in Primary CD4+Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction
Mudit Tyagi, R. J. Pearson, Jonathan Karn
Journal of Virology (2010) Vol. 84, Iss. 13, pp. 6425-6437
Open Access | Times Cited: 244
Mudit Tyagi, R. J. Pearson, Jonathan Karn
Journal of Virology (2010) Vol. 84, Iss. 13, pp. 6425-6437
Open Access | Times Cited: 244
Establishment of HIV-1 latency in resting CD4 + T cells depends on chemokine-induced changes in the actin cytoskeleton
Paul Cameron, Suha Saleh, Georgina Sallmann, et al.
Proceedings of the National Academy of Sciences (2010) Vol. 107, Iss. 39, pp. 16934-16939
Open Access | Times Cited: 225
Paul Cameron, Suha Saleh, Georgina Sallmann, et al.
Proceedings of the National Academy of Sciences (2010) Vol. 107, Iss. 39, pp. 16934-16939
Open Access | Times Cited: 225
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies
Laurence Colin, Carine Van Lint
Retrovirology (2009) Vol. 6, Iss. 1
Open Access | Times Cited: 220
Laurence Colin, Carine Van Lint
Retrovirology (2009) Vol. 6, Iss. 1
Open Access | Times Cited: 220